Thrombopoietin receptor levels in tumor cell lines and primary tumors - Wikidata - awgldk - TriplyDB

Thrombopoietin receptor levels in tumor cell lines and primary tumors

Thrombopoietin receptor levels in tumor cell lines and primary tumors

http://www.wikidata.org/entity/Q33394117

about

Low or undetectable TPO receptor expression in malignant tissue and cell lines derived from breast, lung, and ovarian tumors.Immuno-stimultory/regulatory gene expression patterns in advanced ovarian cancer.Altered B-lymphopoiesis in mice with deregulated thrombopoietin signaling.

P2860

Q33403234-A793DA85-4E71-44B4-B351-4ADAF7A1AF47 Q36248464-4FA958FB-820D-4ACE-BE4B-D9B63888F642 Q48372668-0B6B64F4-C7BB-4A47-A75E-7868E31EFB7E

P2860

Thrombopoietin receptor levels in tumor cell lines and primary tumors

http://www.wikidata.org/entity/Q33394117

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Thrombopoietin receptor levels in tumor cell lines and primary tumors

@ast

Thrombopoietin receptor levels in tumor cell lines and primary tumors

@en

type

label

Thrombopoietin receptor levels in tumor cell lines and primary tumors

@ast

Thrombopoietin receptor levels in tumor cell lines and primary tumors

@en

prefLabel

Thrombopoietin receptor levels in tumor cell lines and primary tumors

@ast

Thrombopoietin receptor levels in tumor cell lines and primary tumors

@en

P1433

Q33394117-10856ECB-AC87-414B-B615-EDA15BE879CF

P1476

Q33394117-811923BC-4982-4393-9875-E210DE9A15DB

P2093

Q33394117-1620044A-DF85-47D2-ACEC-61D3D26E5B13

Q33394117-20AF5BFA-2961-42FF-BBE3-4F2AFDD29B98

Q33394117-233A318E-4FA7-4B4F-B67E-A024BFFFF7A6

Q33394117-46EA438B-4477-4536-AE89-8AEC09C4CA7F

Q33394117-5BFF689D-8894-41BB-9EA3-A82C53A282E3

Q33394117-7CABF894-5FF7-4C66-9387-0F08A9881BCA

Q33394117-8086BA44-8779-4013-84AB-E407B6CC1BFC

Q33394117-8339D740-9B3C-4CF7-AB49-A24300E8A783

Q33394117-A4CE7432-8195-42DD-9811-1DDB3CF13A0B

Q33394117-BC1126A1-F36B-4E1F-B4E7-BB292ABB75A4

P2860

Q33394117-068D7753-FB86-4A16-AE5B-3D3C190B054C

Q33394117-0DB49254-C7BD-4957-8C6E-3065762B296E

Q33394117-13E2A5AD-F3F8-4591-8E44-43C41DE30690

Q33394117-142691C8-D411-42C5-A673-5C9BC36A7DE2

Q33394117-21011248-B27A-401A-8707-365189C29AAF

Q33394117-2A01D3E2-C569-4425-88DD-E2D9901AECC0

Q33394117-2F8F71AC-FE31-40BD-91EC-40D3BA61E192

Q33394117-35C18662-6C9E-4F0C-92DD-A7A758020694

Q33394117-38DB205B-C10C-44A6-95C2-F3F56C90A776

Q33394117-3B925635-3F7D-44E1-BB75-35A61F40C1F7

P304

Q33394117-AF3F45AF-A93D-47A9-B6C0-E7E8C811EAE5

P31

Q33394117-404DA322-266B-48DA-8BB7-AD07447E83F2

P356

Q33394117-07F8DE9F-AD2F-42EF-83D5-94E74E38DBE2

P478

Q33394117-CB8D0841-25D9-428B-877A-5227E85C3623

P577

Q33394117-78EAC215-7644-4E5D-A835-95251F3D1E3A

P5875

Q33394117-B9E75929-067E-4956-8343-790EFDDD4FDA

P698

Q33394117-BFE6F794-90A7-4494-93A5-F5A8B219A79F

P932

Q33394117-20E331D7-41E2-432C-8429-CB5B8ECDA037

P356

P1433

Journal of oncology

P1476

Thrombopoietin receptor levels in tumor cell lines and primary tumors

@en

P2093

Anna Gibbard

http://www.w3.org/2001/XMLSchema#string

Anne-Marie Martin

http://www.w3.org/2001/XMLSchema#string

Antony Chadderton

http://www.w3.org/2001/XMLSchema#string

Connie L Erickson-Miller

http://www.w3.org/2001/XMLSchema#string

Conrad Messam

http://www.w3.org/2001/XMLSchema#string

Iman El-Hariry

http://www.w3.org/2001/XMLSchema#string

Jennifer Kirchner

http://www.w3.org/2001/XMLSchema#string

Katherine Baker

http://www.w3.org/2001/XMLSchema#string

Kodandaram Pillarisetti

http://www.w3.org/2001/XMLSchema#string

Lini Pandite

http://www.w3.org/2001/XMLSchema#string

P2860

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia.

Thrombopoietin and interleukin 11 have different modulatory effects on cell cycle and programmed cell death in primary acute myeloid leukemia cells.

Platelet function in the myelodysplastic syndromes.

Comparison of platelet immunity in patients with SLE and with ITP.

Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection.

Megakaryocyte development and platelet production.

Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist.

Emerging treatments for thrombocytopenia: increasing platelet production.

Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist.

P304

135354

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2010/135354

http://www.w3.org/2001/XMLSchema#string

P478

2010

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49833259

http://www.w3.org/2001/XMLSchema#string

P698

21318160

http://www.w3.org/2001/XMLSchema#string

P932

3026977

http://www.w3.org/2001/XMLSchema#string